Oxtellar XR Shortage Update: What Patients Need to Know in 2026

If you've struggled to fill your Oxtellar XR prescription, you might be wondering whether there's an official shortage. The short answer is nuanced: Oxtellar XR is not on the FDA's official drug shortage list as of 2026, but availability challenges persist for many patients. Here's a comprehensive update on the situation.

Oxtellar XR Shortage Status in 2026

As of 2026, Oxtellar XR (oxcarbazepine extended-release) is NOT on the FDA's official drug shortage database. Supernus Pharmaceuticals continues to manufacture and distribute the medication, and it is covered by most prescription insurance plans. The FDA's official shortage list tracks medications with supply disruptions caused by manufacturing failures, raw material issues, or distribution breakdowns — and Oxtellar XR does not currently meet those criteria.

However, a medication not being on the FDA shortage list doesn't mean patients always find it easily available at their local pharmacy. Oxtellar XR faces practical availability challenges that are separate from an official shortage.

Why Patients Report Difficulty Finding Oxtellar XR

The challenges patients face filling Oxtellar XR stem from its nature as a specialty brand-name medication:

• Not routinely stocked: Many retail pharmacies don't stock Oxtellar XR because demand is lower than high-volume generics. It may need to be specially ordered.
• Insurance routing: Some plans require Oxtellar XR to be filled through specialty pharmacy channels rather than standard retail pharmacies.
• Prior authorization delays: Oxtellar XR may require prior authorization from insurers, especially as a brand-name medication when a generic alternative exists. PA processing can delay access.
• High cost limiting dispensing: At $500-$1,300/month retail, some pharmacies limit their Oxtellar XR inventory due to carrying costs.

What Strengths of Oxtellar XR Are Hardest to Find?

Oxtellar XR comes in three strengths: 150 mg, 300 mg, and 600 mg extended-release tablets. In general:

• 150 mg tablets are the least commonly stocked, as they're used primarily during titration.
• 300 mg tablets are the most common intermediate strength and more often available at larger pharmacies.
• 600 mg tablets are widely used for maintenance dosing and may be more readily available.

What Patients Can Do Right Now

If you're having trouble filling Oxtellar XR, here are your best options: Use medfinder to find which pharmacies near you have Oxtellar XR in stock — medfinder calls pharmacies on your behalf and texts you the results.

1. Ask your pharmacist to order it. Most pharmacies can source Oxtellar XR within 1-2 business days if they don't have it on hand.
2. Contact Supernus Support. Call 1-866-398-0833. They can help connect you with specialty pharmacies that reliably dispense Oxtellar XR.
3. Talk to your neurologist. If Oxtellar XR genuinely cannot be obtained, your prescriber may temporarily authorize immediate-release oxcarbazepine (Trileptal) as a bridge — with appropriate dosage adjustments.
4. Consider mail-order pharmacy. Mail-order allows 90-day fills with reliable delivery, eliminating monthly supply uncertainty.

Never Stop Oxtellar XR Without Medical Guidance

This cannot be emphasized enough: do not stop taking Oxtellar XR abruptly. The FDA prescribing information specifically warns that Oxtellar XR should be withdrawn gradually to reduce the risk of increased seizure frequency and status epilepticus. If you are running low and cannot locate a fill, call your prescriber's office the same day.

The Bottom Line

Oxtellar XR is not in an official FDA-declared shortage in 2026. However, it is a specialty brand-name medication that requires more effort to locate than typical generics. The best strategy is to plan ahead, use tools like medfinder to search pharmacies, and maintain open communication with your prescriber. If you need information on potential alternatives, see our guide to Oxtellar XR alternatives.